Preview Mode Links will not work in preview mode

This Week in Cardiology


Feb 22, 2019

Factor Xa reversal agent Andexa, PTSD, gender transition hormones and CVD, primary care physician shortage, and a commentary from a young interventional cardiologist are discussed this week.